Danaher is launching an AI-powered autonomous lab for drug discovery
The lab, based at Abcam and expected to operate at scale in early 2027, aims to cut the time from idea to validated reagent by up to 8 times
The lab, based at Abcam and expected to operate at scale in early 2027, aims to cut the time from idea to validated reagent by up to 8 times